Philip Tagari, Chief Scientific Officer of insitro, and Vijay Pande discuss the transformative power of drug discovery, evolution of the process with AI, and the future of the industry. Topics include AI-enabled drug engineering, personalized healthcare, and blending tech and life sciences for optimal results.
Medications have a historical impact, like M&B 693 saving Winston Churchill's life, showing drugs' transformative power.
Drug discovery is shifting to AI-enabled engineering for designing drugs efficiently, targeting specific therapeutic actions.
Deep dives
Impact of Medications on Changing Lives and History
The podcast episode discusses the significant impact of medications on changing lives and altering history. It highlights the story of M&B 693, a drug credited with saving Winston Churchill's life during World War II, demonstrating the transformative power of medications in critical situations. The conversation delves into how this historical event showcased the profound difference a drug can make, shifting the perception of medicines from individual impact to potential historical change.
Transition to Machine Learning and AI in Drug Discovery
The episode explores the ongoing transition in drug discovery from traditional methods to utilizing artificial intelligence (AI) and machine learning. It emphasizes the shift from 'finding' drugs in the past to 'designing' drugs based on a wealth of accumulated knowledge across various modalities. By harnessing AI, researchers aim to target specific biological pathways and therapeutic actions more efficiently, revolutionizing the drug discovery process.
Predictions for the Future of Pharma
Looking ahead, the podcast anticipates significant changes in the pharmaceutical industry over the next five to ten years. It predicts a trend towards consolidation in the industry to enhance efficiency and reduce waste. The discussion also emphasizes the role of machine learning in advancing patient stratification, optimizing drug discovery, and ultimately contributing to personalized medicine. Additionally, the episode envisions a future where AI and automation drive care delivery, leading to more targeted and efficient healthcare solutions.
Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.
Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery process as it shifts from serendipitous discovery to AI-enabled engineering. Finally, they chat about where the industry is headed, and how AI might change the competition landscape.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode